CHM chimeric therapeutics limited

At the time her salary was negotiated with the board the...

  1. 1,336 Posts.
    lightbulb Created with Sketch. 231
    At the time her salary was negotiated with the board the liquidity landscape for biotechs was different. If history was different, and had the market bid up the price of CHM, they could have done easy raises in a rising share price environment and had decent justification for paying one individual that much money, and she might have still been CEO today.

    However the market chose to bid CHM DOWN. To the point of suffocation. So looking at where the company is today, the market has decided the answer is clearly YES, she is too expensive in this point of time. The market has also played a big part in the FUTURE history of CHM, as the intense backroom changes in leadership overlapping with frontline drugs hitting arms, this could instantly become a hot space.

    This company is like a person living the highs and lows of a rock n roll superstar!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $46.58K 11.64M

Buyers (Bids)

No. Vol. Price($)
2 2545728 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.